AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00909363 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: blood drawing in patients with WAS
Description: blood will be drawn for platelet parameters in WAS patients not receiving treatment either because they declined or because they were ineligible
Study NCT04527354 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive Placebo once a day during 4 weeks
Study NCT00909363 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: blood drawing in healthy controls
Description: blood will be drawn once in healthy children as controls for platelet parameters
Study NCT02524288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ENG-E2 125 μg/300 μg vaginal ring
Description: Up to 13 cycles of ENG-E2 125 μg/300 μg administered intravaginally, each cycle consisting of 21 days of vaginal ring use followed by 7 vaginal ring-free days.
Study NCT02107378 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DCVAC/OvCa
Description: DCVAC/OvCa is the experimental therapy added on to Paclitaxel or topotecan or doxorubicin
Study NCT01066845 — intervention group
Intervention type: DRUG
Intervention: tadalafil
Description: prescribed in accordance with usual clinical practice
Study NCT00922363 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 µg Ag85B-ESAT-6 alone
Description: 0.5 mL solution for injection x 2 (2 months interval)
Study NCT00922363 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 µg Ag85B-ESAT-6 + 125/25 µg CAF01
Description: 0,5 mL suspension for injection x 2 (2 months interval)
Study NCT00922363 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 µg Ag85B-ESAT-6 + 313/63 µg CAF01
Description: 0.5 mL suspension for injection x 2 (2 months interval)
Study NCT02107378 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (Paclitaxel or topotecan or doxorubicin)
Description: Paclitaxel or topotecan or doxorubicin is Standard of Care First Line Chemotherapy
Study NCT03498170 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: BCT197
Description: Single dose of BCT197
Study NCT03498170 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Itraconazole 200 mg
Description: Single dose of itraconazole
Study NCT01278433 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMOVAX Polio™: Inactivated Poliomyelitis Vaccine
Description: 0.5 mL, Intramuscular
Study NCT01345838 — intervention group
Intervention type: PROCEDURE
Intervention: labrum
Description: Two years follow-up after PAO, to find any differences among patients with and without known acetabular labral tears
Study NCT00166192 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Jessner's solution chemical peel
Study NCT00166192 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trichloroacetic acid chemical peel
Study NCT03145246 — intervention group
Intervention type: PROCEDURE
Intervention: regeneration treated teeth loss
Description: number of regeneration treated teeth loss
Study NCT03145246 — intervention group
Intervention type: PROCEDURE
Intervention: regenerated treated teeth with clinical attachment loss
Description: regenerated treated teeth with clinical attachment loss ≥ 2 mm
Study NCT01555684 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: percutaneous venoplasty to alleviate chronic cerebrospinal venous insufficiency
Description: percutaneous venoplasty is where a balloon is inserted and inflated into the jugular vein has been developed to improve this drainage of the CNS, reduce venous hypertension and improve symptoms associated with MS
Study NCT01555684 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: percutaneous venoplasty to alleviate chronic cerebrospinal venous insufficiency
Description: percutaneous venoplasty is where a balloon is inserted and inflated into the jugular vein has been developed to improve this drainage of the CNS, reduce venous hypertension and improve symptoms associated with MS
Study NCT03206736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Loop DS surgery
Description: these patients will receive a loop DS bariatric procedure
Study NCT04224181 — intervention group
Intervention type: RADIATION
Intervention: Cardiac PET
Description: A scan examining blood flow to the heart
Study NCT04224181 — intervention group
Intervention type: RADIATION
Intervention: 99mTc-tilmanocept SPECT/CT
Description: A scan to look at inflammation in the arteries
Study NCT04224181 — intervention group
Intervention type: RADIATION
Intervention: Contrast Enhanced Coronary and Aortic Computed Tomography Angiography
Description: A scan of the heart and surrounding blood vessels
Study NCT03631537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NST group
Description: Nutrition-support-team based intervention on nutrition, including dietary supplement, parenteral nutrient solutions and patient education
Study NCT04982120 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repris Needle
Description: Injection of Botox
Study NCT02504476 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AMG 581
Description: Active drug
Study NCT02504476 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: AMG 581
Description: Active drug
Study NCT02504476 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AMG 581
Description: Active drug
Study NCT02504476 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02504476 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Midazolam
Description: Interaction
Study NCT01300468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PHA-848125AC
Study NCT00421343 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: alendronate with cholecalciferol
Description: alendronate 70mg /cholecalciferol 2800IU orally once weekly
Study NCT00421343 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: calcium carbonate with cholecalciferol
Description: calcium carbonate 500mg /cholecalciferol 200IU orally twice daily
Study NCT00421343 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Falls prevention measures
Description: personalized exercises, home safety evaluation, referral to an eye doctor if needed, review of medications
Study NCT02551133 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone
Description: 1 hour before surgery
Study NCT04645472 — intervention group
Intervention type: DEVICE
Intervention: CT-Ultrasound
Description: For patients with kidney stones who are planning to undergo PCNL, perform a preoperative simulated CT-ultrasound fusion examination to further clarify the condition of the kidney stones and simulate and optimize the puncture route. Apply CT- Ultrasound fusion precise positioning to guide the intraoperative PCNL puncture process.
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-120
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-221
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: daunorubicin
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: idarubicin
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone
Study NCT02632708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Study NCT01907594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: D-cycloserine
Study NCT01907594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine Replacement Therapy (patch)
Study NCT01907594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nicotine Replacement Therapy (patch)
Study NCT01907594 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking Cue Exposure
Study NCT01907594 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Smoking Cue Exposure
Study NCT01907594 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Muscle Relaxation
Study NCT01907594 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Progressive Muscle Relaxation
Study NCT01907594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The investigators will administer Gelatin Capsule instead of D-Cycloserine in a double blind fashion to some of study subjects.
Study NCT04229550 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Festival participation
Description: One week's participation in Roskilde Festival 2016 or living a normal daily life.
Study NCT02302794 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: open surgery
Description: Patients in this arm undergo radical resection of gastric cancer in open surgery.Open surgery is a conventional technique for gastric cancer patients.
Study NCT02302794 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laparoscopic surgery
Description: Patients in this arm undergo radical resection of gastric cancer in laparoscopic surgery.Laparoscopic surgery is a new and minimum invasive technique for gastric cancer patients.
Study NCT02781467 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PNK-007
Study NCT02781467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02781467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Study NCT02781467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human recombinant Interleukin-2 (rhIL-2)
Study NCT02538588 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nebulizer 1
Study NCT02538588 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nebulizer 2
Study NCT01926054 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acthar gel
Study NCT02437097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: The research design used will be a randomized control trial using a Latin square in order to randomize the treatment conditions. Subjects will take one of four conditions: 1) Aerobic exercise only 2) Aerobic exercise and Gaming simultaneously 3) Gaming only 4) Sitting quietly. All the conditions will take 30 minutes. The independent variables are the four conditions and the dependent variables are the Stroop test and modified Trails B which measure executive function.
Study NCT02437097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Gaming
Description: The research design used will be a randomized control trial using a Latin square in order to randomize the treatment conditions. Subjects will take one of four conditions: 1) Aerobic exercise only 2) Aerobic exercise and Gaming simultaneously 3) Gaming only 4) Sitting quietly. All the conditions will take 30 minutes. The independent variables are the four conditions and the dependent variables are the Stroop test and modified Trails B which measure executive function.
Study NCT02437097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise and Video Gaming
Description: The research design used will be a randomized control trial using a Latin square in order to randomize the treatment conditions. Subjects will take one of four conditions: 1) Aerobic exercise only 2) Aerobic exercise and Gaming simultaneously 3) Gaming only 4) Sitting quietly. All the conditions will take 30 minutes. The independent variables are the four conditions and the dependent variables are the Stroop test and modified Trails B which measure executive function.
Study NCT02437097 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: The research design used will be a randomized control trial using a Latin square in order to randomize the treatment conditions. Subjects will take one of four conditions: 1) Aerobic exercise only 2) Aerobic exercise and Gaming simultaneously 3) Gaming only 4) Sitting quietly. All the conditions will take 30 minutes. The independent variables are the four conditions and the dependent variables are the Stroop test and modified Trails B which measure executive function.
Study NCT02469337 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dichloroacetate
Description: Dichloroacetate, an analog of acetic acid has been shown to increase the activation of PDC by inhibiting PDK4 in humans. This drug is expected to shift the metabolism of pyruvate from glycolysis and towards oxidative pathway in the mitochondria
Study NCT02469337 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carbohydrate drinks
Description: preoperative carbohydrate drinks
Study NCT02469337 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Moderate intensity exercise
Description: 30 min exercise using a semi-recumbent exercise bike, at about 70% of their age estimated heart rate
Study NCT03936348 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exercise training program with and without FB
Description: Participants carried out a supervised RP for 8 weeks, 3 days per week. The training sessions lasted 60 minutes and included a warning up phase, the main phase and a recovery phase. After each session, Borg's perceived exertion was measured. The Rehabilitation Program (RP) included aerobic exercise on cycle ergometer and on treadmill (progressing since 10' to 30' and since 40 to 75% of the reserve heart rate (RHR) or 6-7 score based on Borg's perceived exertion), strengthening of lower and upper limb muscles groups, breathing exercises (pursed lip breathing, diaphragmatic and abdominal breathing and diaphragmatic mobility) and finally stretching exercises.~In the FB group, for restricted nasal breathing, at the beginning of the training program, the small size device was used (4 mm). The size of the device was progressively increasing according to the patient adaptation to the 5 or 6 mm device, depending on the score on Borg's perceived exertion scale.
Study NCT01765686 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Harmonic Scalpel (Ethicon Endo-Surgery, USA)
Study NCT01765686 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ligasure Small Jaw (Covidien, USA)
Study NCT02491749 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultra Fast-Track Anesthesia
Description: early extubation at the end or within one hour post operatively
Study NCT02582437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: History for opioid use
Study NCT00509639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10% Metronidazole Ointment
Description: Metronidazole 10% ointment applied perianally three times daily for four weeks. Placebo ointment applied perianally three times daily for four weeks
Study NCT01076556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alvocidib Hydrochloride
Description: Given IV
Study NCT01076556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT01076556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diagnostic Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01076556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT01076556 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given IV
Study NCT05734209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual food
Description: Virtual food eaten using immersive virtual reality equipment
Study NCT05734209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Real food
Description: Real food eaten using regular utensils
Study NCT02875041 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS)
Study NCT02875041 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MAGSTIM Rapid2
Study NCT00487929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nasal CPAP
Description: Nocturnal
Study NCT00487929 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham CPAP
Description: Nocturnal
Study NCT01911806 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Back care pillow
Description: back care pillow is specific size by age groups of standard deviation of the lumbar spinal curvature, in 20-29 years was 51.68 ± 6.94 degrees, in 30-39 years was 59.67 ± 7.02 degrees, in 40-49 years was 63.66 ± 7.62 degrees, in 50-59 years was 65.75 ± 10.85 degrees and in 60-69 years was 64.19 ± 9.69 degrees
Study NCT01911806 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: standard physical therapy treatment
Description: standard physical therapy treatment are ultrasound therapy and hot pack
Study NCT01911806 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: standard physical therapy treatment
Description: standard physical therapy treatment are ultrasound therapy and hot pack
Study NCT00922363 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 µg Ag85B-ESAT-6 + 625/125 µg CAF01
Description: 0.5 mL suspension for injection x 2 (2 months interval)
Study NCT01621646 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: eggs or egg whites
Description: 2 eggs/day or 4 oz egg whites/day for 6 months
Study NCT01621646 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eggs or egg whites
Description: 2 eggs/day or 4 oz egg whites/day for 6 months
Study NCT00855361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole sodium
Description: One single daily dose of rabeprazole sodium 1 mg as a microgranule formulation for up to 28 consecutive days (Part 1), and one single daily dose of rabeprazole sodium 2 or 3 mg as a microgranule formulation for up to 28 consecutive days (Part 2). The study drug will be administered through a nasogastric or orogastric tube.
Study NCT02883517 — intervention group
Intervention type: GENETIC
Intervention: Cytogenetic and molecular studies
Description: Detect cell-free circulating tumoral DNA in a blood sample, with correlations with clinical characteristics and metastatic outcome.
Study NCT00739973 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT00681070 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Arm 2: Absorbable sutures
Description: use of absorbable catgut sutures in pediatric facial lacerations
Study NCT03811223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evolocumab Auto-Injector [Repatha]
Description: Evolocumab 140 mg every 2 weeks for 12 weeks
Study NCT03811223 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo subcutaneous injection every 2 weeks for 12 weeks
Study NCT04106427 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: continuous theta burst stimulation (cTBS)
Description: cTBS stimulation of 17 mins over right inferior parietal lobe (IPL) with two 44 s stimulations separated by 15 mins, 10 sessions in total (5 per week). intensity will be 100% of resting motor threshold at 30 Hz.~administered in weeks 1 and 2 of the trial
Study NCT04106427 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: placebo cTBS
Description: Placebo stimulation of 17 mins over right IPL with two 44 s stimulations separated by 15 mins, 10 sessions in total (5 per week). intensity will be 0% of resting motor threshold at 30 Hz.~administered in weeks 1 and 2 of the trial
Study NCT04106427 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: social cognitive remediation therapy (SCRT)
Description: 16 sessions of group SCRT will be scheduled within 8 weeks, comprising 6-8 participants per group with 2 therapists. Duration of group sessions will be 60-90 mins. The content will follow the manual of SCRT and we will add a short intervention to practice the use of co-speech gestures at each session
Study NCT04106427 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: social cognitive remediation therapy (SCRT)
Description: 16 sessions of group SCRT will be scheduled within 8 weeks, comprising 6-8 participants per group with 2 therapists. Duration of group sessions will be 60-90 mins. The content will follow the manual of SCRT and we will add a short intervention to practice the use of co-speech gestures at each session
Study NCT04106427 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham group therapy
Description: Group activities in closed groups of 6 participants. Schedule of two sessions per week for 8 weeks. Two therapists are guiding different leisure activities, e.g. group walks, going to museums/movies, games.
Study NCT00681070 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Arm 1: non-absorbable sutures
Description: Use of non-absorbing sutures
Study NCT01195597 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: E-Cigarette 7.2 mg nicotine
Description: Participants were given a free e-Cigarette kit containing two rechargeable batteries, a charger, and two atomizers and instructed on how to charge, activate and use the e-Cigarette. Key troubleshooting were addressed and phone numbers were supplied for both technical and medical assistance. A full 4-weeks supply of 7.2 mg nicotine cartridges (Original cartridges; Arbi Group Srl, Milano, Italy) was also provided and participants were trained on how to load them onto the e-Cigarette's atomizer
Study NCT01785030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 50% Nitrous oxide
Study NCT03517917 — intervention group
Intervention type: OTHER
Intervention: Tumour tissue collection
Description: Collection of tumour tissue and blood